DrugChatter: Can you verify apotex s ruxolitinib us filing date?
Ruxolitinib: A Breakthrough Treatment for Myelofibrosis, But When Will It Hit the Market?Myelofibrosis, a rare and debilitating blood disorder, has long been a challenge for patients and healthcare providers alike. The disease is characterized by the a…
DrugChatter: Can you verify apotex s ruxolitinib us filing date? Read Post »